Barclays Maintains Underweight on NOV, Raises Price Target to $21
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $20 to $21.
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $20 to $21.